We offer customized solutions for expression of a wide variety of stable, high-expressing therapeutic proteins. At CELLTHEON, our scientific experts are known for providing high quality, reliability, productivity and affordability to our clients. Our innovative technologies and services will lead to:
The Celltheon SMART™ technology platform has been used to generate a number of biosimilar and novel molecules such as monoclonal antibodies, Fabs, recombinant proteins and enzymes from research to Phase 3. Celltheon is in partnership with a number of small to large pharmaceutical companies here in the U.S and internationally to provide SMART solutions for a number of disease indications such as oncology, inflammation, neurodegeneration, obesity, and various lysosomal storage disorders.
Celltheon's services can be applied to the research, optimization and development phase of a project. Our services are highly collaborative, well-documented and timely, giving you control over the entire process.
Our customer dedicated research teams ensure that your project gets the attention and focus that lead to success. Further, we assign a project manager for each project that pays close attention to your project and keeps you updated on the progress of the project.
Our current clients are routinely recurring and will be happy to provide a great reference for our services, be it - cell line development, process optimization, purification, assay development or production of GLP tox material.